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CHAPTER I 
INTRODUCTION 
Amygdalin has been used as an anticancer agent for many centu-
ries. Dating back to circa 2800 B.C., during the reign of China's 
Emperor Shen Nung, the apricot kernel and other amygdalin bearing 
plants were used for cancer treatment (Halstead, 1977). In England, 
during the seventeenth century, apricot oil was used against tumors 
or swellings of ulcers (Lewis and Elvin-Lewis, 1977). In a study 
sponsored by the National Cancer Institute, Wodinsky and Swiniarski 
(1975) state that "amygdalin found in the kernels of bitter almonds, 
peaches, and apricots, has been used in cancer chemotherapy since 
1845." Currently pure amygdalin, isolated from apricot kernels, is 
being used, legally in many foreign countries and in many states of 
the United States. 
Amygdalin is one of the most widely distributed cyanogenic gly-
cosides. It is commonly found in members of the Rosaceae (rose family) 
(Lewis and Elvin-Lewis, 1977). Amygdalin is also known variously as 
nitrilosides, Laetrile, or Vitamin B17· Upon hydrolysis of amygdalin, 
a two-step process, two molecules of glucose are released as well as 
benzaldehyde, and hydrocyanic acid (Montgomery, 1969). In 1950 Ernst 
T. Krebs, Jr. theorized that it was the hydrogen cyanide released from 
amygdalin that exerted its antineoplastic effects on cancer cells 
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(Griffin, 1974). 
The exact mechanism of action of amygdalin is not known, but 
several hypotheses have been presented (Halstead, 1977). The most 
widespread theory on the action of amygdalin has been forwarded by 
Ernst T. Krebs, Sr. and Jr .. According to them, amygdalin is broken 
down in the body by enzymes, and it is due to varying concentrations 
of those enzymes that it has a specific effect. Cancer cells have 
high levels of the enzymes B-glucosidase and B-glucuronidase which 
break down amygdalin and liberate hydrogen cyanide (Fishman andAnlyan, 
1947; Haisman and Knight, 1967; Culbert, 1974; Krebs, 1967, 1970). 
According to the Krebs' theory it is the high concentration of B-
glucuronidase found in cancer cells that allows for the selective re-
lease of hydrogen cyanide from the amygdalin at the cancer site (Krebs, 
1970). Normal cells are protected from the hydrogen cyanide by the 
presence of the enzyme rhodanese which converts hydrocyanic acid to 
thiocyanate (Mendel, Rudney and Bowman, 1946; Giordano et al., 1956; 
Oke, 1969). Hydrolysis of amygdalin is a two-step oxidative process 
and its occurence in the body has not been established scientifically. 
Much of the Krebs' "cyanide theory" is based upon work done 
previously by Beard (1902). According to Beard's "Trophoblastic 
Thesis of Cancer", the cancer cell is the same as the trophoblast cell 
in pregnancy. In some instances, however, the trophoblast cell, 
which is normal during pregnancy, becomes misguided and under the in-
fluence of the sex hormone estrogen is transformed into a malignant 
cell. After further investigation of Beard's theory, Krebs et al. 
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(1950) published a paper indicating that the trophoblast cell in preg-
nancy was inhibited by pancreatic enzymes and they inferred that the 
trophoblast cell outside of pregnancy (the malignant cell) should also 
be inhibited by the pancreatic enzymes. Krebs, Jr. experimented fur-
ther with the use of pancreatic enzymes against cancer, and he claimed 
to have had some positive results using chymotrypsin, but he noted 
that it lacked the force to do the specific job that Beard had attrib-
uted to it in his theory (Culbert, 1974). So, Krebs, Jr. continued 
with his research in this area, which ultimately led him to the form-
ulation of an extract from apricots, which he called "Laetrile". 
Currently, amygdalin is being used in the form of Krebs' 
Laetrile. Krebs, Jr. first reported in 1950 that he had synthesized 
this compound from the apricot kernel (Griffin, 1974) . He came up 
with the word Laetrile since it was derived from a laevorotarynitrile 
and subsequently patented the compound. The main difference betwen 
amygdalin and Laetrile is that amygdalin contains 2 glucose molecules 
and Laetrile has only one. 
In addition to therapeutic use, it has been proposed by propo-
nents of amygdalin that by maintaining an adequate level of amygdalin 
in one's diet, it will have a specific cancer preventative and control-
ling effect (Krebs, 1970; Larson, 1972; Griffin, 1974; Culbert, 1974). 
The theory that amygdalin actually prevents or retards the growth of 
cancer cells is based on two lines of reasoning. One is that doctors 
who have used nitrilosides on thousands of patients are enthusiastic 
about the results. They do not claim that it cures cancer, only that 
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in many instances it halts the deadly progress of the disease. The 
other line of reasoning is that so-called primitive peoples, in whom 
most forms of cancer are extremely rare, eat a diet containing a large 
amount of amygdalin. Conversely, in nations where cancer is near the 
top of the killer list, the diet contains very little or no nitrile-
sides (Krebs, 1967; Larson, 1972; Griffin, 1974). 
Experimental evidence to support the theory that amygdalin is 
cancer preventive is somewhat limited, however it is still used by 
many people throughout the world for that purpose. A report by Stock 
et al. (1978) indicates that in mice injected intraperitoneally with 
amygdalin at a dosage of 1000 mg/kg/day, 17% developed lung metastases 
and 72% tumors. In the control group, 81% developed lung metastases 
and 82% tumors. In France, Metianu (1977) treated mice subcutaneous-
ly two to three times per week with 500 mg/kg of amygdalin after inno-
culating them with 5 x 10 8 cells of adenocarcinoma. The experimental 
group lived an average of 58 days past the time of tumor take and the 
controls survived an average of 21 days. In West Germany it was found 
that in mice with Ehrlich Ascites Carcinoma, bitter almonds given in 
addition to standard feed in a free food choice caused a significant 
prolongation of survival time, which could be associated with inhibi-
tion of tumor growth (Reitnauer, 1974). Manner et al. (1978), reports 
that when amygdalin is used in conjunction with megadoses of Vitamin 
A and certain enzymes, there is complete regression of primarymammary 
tumors in C3H/HeJ mice in 89.3% of the cases. No study has been done 
on the effects of naturally occurring amygdalin (apricot kernels) on 
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the prevention of spontaneous mammary tumors in female C3H/HeJ mice. 
Although many toxicity studies on amygdalin have been carried 
out, they lack uniformity. Trube-Becker (1965) estimated that 50-70 
raw almond kernels would have to be eaten to provide a lethal dose to 
adults and as few as 7-10 almonds for a child. Burk (1971) found that 
amygdalin in doses as high as 10 gm/kg were non-toxic to adult animals. 
Amygdalin administered intramuscularly in doses ranging from 1000-2500 
mg/kg for 15 days was found to be non-toxic (Manner, DiSanti and 
Michalsen, 1977). Hill~ al. (1976) reported no toxicity with doses 
ranging from 50 to 500 mg/kg for 4 days, but when doses reached 2000 
mg/kg for 4 days there was a five percent death rate. Amygdalin MF 
used by Wodinsky and Swiniarski (1975) at 800 mg/kg intraperitoneally, 
on mice for nine days showed no toxic effects. However, Khandekar and 
Edelman (1979) indicate that amygdalin given to Fischer 344 rats in 
doses of 250, 500, and 750 mg/kg intraperitoneally daily for five days 
caused mortalities of 30.8%, 44.1%, and 56.8% respectively. There are 
also a number of articles in the literature associating fatal cyanide 
poisoning with the ingestion of amygdalin (Pijoan, 1942; Sayre and 
Kaymakcalan, 1964; Townsend and Bani, 1975; Humbert et al., 1977; 
Sadoff et al., 1978). More recently though, it was reported that six 
patients receiving Laetrile either intravenously or orally experienced 
no toxic effects that could be directly ascribed to Laetrile therapy 
(Henney, 1980). Certainly, it is evident that the question of amyg-
dalin toxicity is unclear. 
The purpose of the present study is to evaluate the importance 
of naturally occurring amygdalin (apricot kernels) in the prevention 
of spontaneous mammary tumors in female C3H/HeJ mice and to look at 
its effects on longevity and the time required for initial tumor ap-
pearance. This study will also look for any possible toxic effects 
when amygdalin is administered by this route. 
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CHAPTER II 
REVIEW OF RELATED LITERATURE 
AHYGDALIN 
Amygdalin belongs to a family of compounds known as cyanogenic 
glycosides. A cyanogenic glycoside is a compound containing sugar and 
having the capacity of producing prussic acid or hydrocyanic acid 
(Halstead, 1977). Other members of this family include prunasin, lina-
marin, sambunigrin, lotusin and dhurrin. 
Amygdalin is one of the earliest investigated cyanogenic glyco-
sides. It was first isolated from bitter almonds by the French chem-
ists Robiquet and Boutron-Charland in 1830. Its chemical properties 
were first worked out by Liebig and Wohler (1837) where they indicated 
that amygdalin was hydrolyzed with the evolution of benzaldehyde and 
hydrogen cyanide by an enzyme preparation from bitter almonds, which 
they called "emulsin". The word "amygdalin" is derived from the Greek 
word "amygdale", meaning almond. Amygdalin is listed in the Merck 
Index (1976) and is described as D-mandelonitrile-B-D-glucosido-6-B-
D-glucoside. The empirical formula of amygdalin is c20H27 No 11 and its 
molecular weight is 457.42. The elemental composition is C 52.51%, H 
5.95%, N 3.06%, and 0 38.47%. (See Figure 1 for the molecular struc-
ture). 
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FIGURE 1. Amygdalin 
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The term amygdalin is often used interchangeably with the word 
Laetrile. Laetrile is the form of amygdalin which is currently being 
used by cancer patients seeking therapeutic benefits. However, amyg-
dalin and Laetrile are not chemically synonymous compounds. In 1950, 
Krebs, Jr. coined the term Laetrile by combining the last five letters 
of the suffix -nitrile with the first three letters of laevorotary, 
since the compound was a laevorotary nitrile (Manner et al., 1978). 
In the Merck Index (1976), Laetrile is defined as 1-mandelonitrile-B-
glucuronic acid. It has an empirical formula of c 14H15N0 7 and a mole-
cular weight of 309.27. The elemental composition is C 54.37%, H 
4.89%, N 4.53% and 0 36.21%. (See Figure 2 for the molecular struc-
ture). Laetrile may be synthesized by the hydrolysis of amygdalin and 
oxidation of the resulting 1-mandelonitrile with platinum black; by 
the condensation of mandelonitrile with glucuronic acid; or by the 
condensation of mandelonitrile with glucose and subsequent oxidation 
(Krebs and Krebs, 1958). Although some confusion arises between the 
use of the two terms amygdalin and Laetrile, Krebs, Jr. designates 
the term Laetrile to refer to any beta-cyanogenic glucosides which in-
clude amygdalin and any of its chemical derivatives (Halstead, 1977). 
NATURAL SOURCES OF AMYGDALIN 
Amygdalin is most commonly found in members of the Rosaceae 
(rose) family. It is found in large quantities in the seeds of apples 
and pears and in the kernels, bark, and leaves of apricots, bitter al-
monds, wild and domestic cherries, peaches and plus (Lewis and Elvin-
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FIGURE 2. Laetrile 
COOH 
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Lewis, 1977). In addition to the seeds and kernels above, cyanogenic 
glycosides are also present in millet, cassava, maize, sorghum, field 
bean, lima bean, bamboo, sugar-cane, kidney bean, sweet potato, let-
tuce and linseed as well as 150 other foods. Table I gives a more 
complete listing. 
Cyanogenic glycosides can be found in a wide range of plants. 
Tableii presents a selected number of these plants. A great number 
of genera may also be found in the allied Fabaceae (pea family), as 
well as in the totally unrelated Poaceae (grass family). Thus, in 
terms of phylogeny, the cyanogenic glucosides exhibit a wide and re-
peatedly independent origin (Lewis and Elvin-Lewis, 1977). 
Extraction of amygdalin is a relatively simple procedure. Apri-
cot kernels are first ground up and then defatted using ether as a 
solvent. The defatted residue is boiled in alcohol, filtered and 
cooled. The amygdalin is then separated from this residue and recrys-
tallized. It is estimated that 33 kernels are needed for each 500 mg 
tablet and 200 kernels for 3 grams of the intravenous formulation 
(Holden, 1976). 
SUGGESTED MECHANISMS OF ACTION OF AMYGDALIN 
Krebs, Jr. introduced the compound Laetrile in the early 1950's 
(Krebs, Jr. et al., 1958). He claimed it to be a beta-glucuronide 
analog of amygdalin, in which the gentiobiose portion of amygdalin 
was replaced by a glucuronic acid molecule. He postulated that this 
molecule could be hydrolyzed by the enzyme beta-glucuronidase thereby, 
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TABLE I. Foods containing amygdalin (from Timms~ al.). 
BEANS KERNELS OR SEEDS OF FRUITS_~~ 
Broad Bean (Vicia Faba) 
Burma Beans 
Chick Peas 
Lentils (sprouted) 
Lima 
Mung Beans (sprouted) 
Rangoon 
Scarlet Runner 
BERRIES 
Almost all wild berries 
Blackberry 
Chokeberry 
Christmas berry 
Cranberry 
Elderberry 
Raspberry 
Strawberry 
GRASSES 
Acacia 
Alfalfa (sprouted) 
Aquatic Grass 
Johnson Grass 
Milkweed 
Sudan Grass 
Tunus Grass 
Velvet Grass 
Wheat Grass 
White Clover 
GRAINS 
Oat Groats 
Barley 
Brown Rice 
Buckwheat Groats 
Chi a 
Flax 
}til let 
Rye 
Vetch 
Hheat Berries 
Apple 
Apricot 
Cherry 
Nectarine 
Peach 
Pear 
Plum 
Prune 
NUTS 
Bitter Almonds 
Macadamia Nuts 
SEEDS 
Chia Seed 
Flax Seed 
Sesame Seed 
MISCELLANEOUS 
Bamboo Shoots 
Fuschia Plants 
Sorghum Plant 
Hild Hydrangea 
Yew Tree (needles; fresh leaves) 
*Contain the highest concentration of 
amygdalin. 
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TABLE II. Important plants containing cyanogenic glycosides, arranged 
phylogenetically (from Pammel). 
Angiosperms: Dicotyledons 
Q1ENOPODIACEAE. Suckleya 
PASSIFLORACEAE. Adenia, Passiflora 
EUPHORBIACEAE. Manihot, Stillingia 
ROSACEAE. Cercocarpus, Cotoneaster, Eriobotrya, ~alus, Prunus, Pyrus, 
Rhodotypos 
FABACEAE. Acacia, Cassia, Colichos, Lotus, Phaseolus, Trifolium, Vicia 
SAXIFRAGACEAE. Hydrangea 
MYRTACEAE. Eucalyptus 
LINACEAE. Linum 
OLACACEAE. Ximenia 
CAPRIFOLIACEAE. Sambucus 
BIGNONIACEAE. Crescentia 
ASTERACEAE. Ageratum, Bahia, Florestina 
Angiosperms: Monocotyledons 
JUNCAGINACEAE. Triglochin 
POACEAE. Cynodon, Glyceria, Holcus, Panicum, Sorghum, Zea 
releasing its constituent parts: hydrocyanic acid and benzaldehyde. 
It has been substantiated for some time now that tumor tissue 
contains a higher concentration of beta-glucuronidase (Fishman and 
Anlyan, 1947). Krebs therefore proposed that Laetrile was releasing 
cyanide selectively at the site of the cancer due to hydrolysis by 
beta-glucuronidase (Krebs, 1967). However, this claim was disproved 
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as it was shown that Krebs' Laetrile was actually the same as amygdalin 
which is not broken down by beta-glucuronidase. It has been shown that 
the hydrolysis of amygdalin is accomplished by the enzyme beta-glucosi-
dase (Haisman and Knight, 1967). Using chromatographic analysis, they 
indicated that the enzymatic hydrolysis of amygdalin by beta-glucosi-
dase occurs in three steps: first the amygdalin is hydrolyzed to pruna-
sin (D-1-mandelonitrile-B-glucoside) and glucose; next, prunasin is 
hydrolized to D-1-mandelonitrile and glucose; finally, the D-1-mandelo-
nitrile is converted to hydrocyanic acid. Refer to Figure 3. 
With this in mind, Krebs then made an alteration in his "cyanide 
theory" (Greenburg, 1975; Halstead, 1977). He proposed that amygdalin 
was first being converted to a glucuronide derivative in the liver, 
which is then circulated to the tumor site where it undergoes hydroly-
sis by the enzyme beta-glucuronidase, thereby releasing its hydrocyanic 
acid. This process would require two hydrolytic cleavages by liver 
beta-glucosidase followed by the conjugation of the resulting mandelo-
nitrile with glucuronic acid by UDP glucuronosyl transferase, but this 
exact process has not been experimentally demonstrated (Halstead, 1977). 
However, it has been shown that glucuronide formation does occur in the 
FIGURE 3. Degradation of amygdalin. 
AMYGDALIN 
+ (beta-glucosidase) 
MANDELONITRILE-GLUCOSDIE + GLUCOSE 
(PRUNASIN) 
HzO + (beta-glucosidase) 
MANDELONITRILE + GLUCOSE 
+ (hydroxynitrilase) 
HCN + BENZALDEHYDE 
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liver and to a lesser extt:tent in the intestines and kidneys (Levvy and 
Conchie, 1966; Mlettlnen and Leskinen, 1970; White et al. , 1973) .. In 
addition, research done bdby Fishman and Anlyan (1947) demonstrates that 
beta-glucuronidase is pre9esent in cancerous tissue of the breast, uterus, 
stomach, mesentery, abdomonninal wall and esophagus about 100-3600 times 
higher than non-cancerouszs tissue. 
Currently, Krebs' version of amygdalin's mechanism of action is 
as follows: cancer cells ~ have unusually high concentrations of beta-
glucosidase, and little o~oor no rhodanese (the enzyme which detoxifies 
cyanide, producing thiocyoyyanate). The cyanide, being selectively re-
leased at the tumor site, ,, then exerts its cytotoxic effects. Research 
by Manner~ al. supports 2S Krebs' claim. They showed that there is a 
higher concentration of beC>eta-glucosidase in the mammary tumor and the 
liver of tumor and non-tumLJmor bearing mice in comparison with the brain 
and muscle tissue of both n tumor and non-tumor bearing mice. Hmvever, 
in vitro experiments have ~ repeatedly shown the inability of cancer 
cells to release cyanide fi from amygdalin within a reasonable incubation 
time (Hodges, 1974). 
An alternative propqoposal for amygdalin's action is that it is 
hydrolyzed to hydrocyanic acid at sites other than the tumor, such as 
the intestine or possibly v the liver. It has been established scientif-
ically that amygdalin is ij indeed hydrolyzed in the intestinal lumen by 
bacterial enzymes (Newton net al., 1981; Carteret al., 1980). The high 
beta-glucosidase content oo of gut bacteria explains amygdalin's greater 
oral toxicity. According t•j to this proposal, after amygdalin is hydrolyzed 
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in the gut it is absorbed into the lymph and portal circulations, cre-
ating a low serum cyanide level which is non-toxic to the host, but to 
which tumor tissue is selectively sensitive. 
BETA-GLUCOSIDASE 
Beta-glucosidase (EC 3.2.1.21) is known chemically as B-D-gluco-
side glucohydrolase. It is a hydrolytic enzyme with an optimum pH of 
4.4 to 5.0 (Barman, 1969). It is a lysosomal enzyme and may be found 
in varying amounts in animal tissues (Manner et al., 1978). The ter1n 
emulsin was originally used to designate this enzyme, but later work 
showed that emulsin was a mixture of enzymes containing, among others, 
the specific enzymes beta-glucosidase and beta-oxynitrilase. Beta-
glucosidase is specific for the beta-D-glucoside linkage upon which it 
exerts its hydrolytic action (Greenberg, 1975). 
BETA-GLUCURONIDASE 
Beta-glucuronidase (EC 3.2.1.31) is known chemically as B-D-
glucuronide glucuronohydrolase. It is a hydrolytic enzyme with an op-
timum pH of 4.3 to 5.0. This enzyme attacks all the natural B-D-gluco-
siduronates whether glycoside- or acylal-linked, aliphatic or aromatic, 
however, it is without activity on A-glucuronides of B-glucosides 
(Barman, 1969). It is a lysosomal enzyme and is universally distrib-
uted in mammalian tissues. It is believed that this enzyme is under 
endocrine control, but its function in the body remains obscure 
(Conchie et al., 1961). Levvy and Marsh (1960) indicated that B-glu-
curonidase plays a role in the catabolism of mucopolysaccharides. It 
also appears to be associated with an increase in cell proliferation 
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(Kerr et al., 1949). Fishman and Anlyan (1947) believe that elevated 
B-glucuronidase is probably a characteristic of malignant cells, but 
that high B-glucuronidase activity in a tissue does not necessarily 
imply malignant change. 
RHODANESE 
Rhodanese (EC 2.8.1.1) is known chemically as thiosulphate sul-
phurtransferase. It is a mitochondrial enzyme and belongs to a group 
of enzymes called transferases (Barman, 1969). Dog liver rhodanese is 
thermolabile, being inactive at 56°, and has optimum activity at about 
body temperature (38°) and pH 8. 3 (Hilliams, 1959). Rhodanese catalyzes 
the formation of thiocyanate from thiosulfate and cyanide. 
The main pathway for cyanide detoxification is conversion to 
thiocyanate. Rhodanese is specific for hydrogen cyanide and converts 
it very rapidly in the presence of sodium thiosulphate or colloidal 
sulphur into thiocyanic acid. As can be seen in Figure 4 when rhodan-
ese is activated with sodium thiosulphate, it binds a sulphur atom in 
a charge-transfer complex to the indole nucleus of tryptophan. Thio-
cyanate is then formed by a nucleophilic attack of cyanide on the sul-
phur-rhodanese complex (Ferris, 1970). Thus, rhodanese has the ability 
to neutralize hydrogen cyanide (Osuntokun, 1970; Montgomery, 1969; Oke, 
1969). 
Cyanide detoxification in the animal body was first shown by 
Lang (1933) who demonstrated that after the injection of cyanide or of 
aliphatic nitriles in the rabbit, an increased amount of thiocyanate 
FIGURE 4. Cyanide detoxification by rhodanese. 
E + ssof 
ES + CN-
-+ ES + so~-
-+ E + seN-
(E rhodanese) 
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was excreted in the urine. Rhodanese is present in nearly all animal 
tissue except in the blood. Rosenthal (1948) and Westley (1973) found 
spleen and kidney cancer cells to have a lower concentration of rhodan-
ese in comparison to the liver. In the dog, the liver being a major 
detoxification organ, contains the major part of the body's supply of 
rhodanese. Lang (1933) found that the amount of liver rhodanese varies 
from one species of animal to another. According to Lang the rabbit 
has twenty times as much of the enzyme per 100 grams as does dog liver, 
and the cow ten times as much. This could be attributed to the fact 
that the rabbit and the cow are herbivorous. The human has three times 
as much of the enzyme as the dog. Data from Himwich and Saunders (1948) 
suggest that even though the liver undoubtedly plays a major role in 
removing cyanide, detoxification probably occurs in all parts of the 
body. They also calculated that the whole liver of a dog can theoreti-
cally detoxify about 4015 grams of cyanide and the total skeletal mus-
cles 1763 grams to thiocyanate within 15 minutes. However, because the 
fatal dose of cyanide is so relatively small, they suggest that avail-
ability of sulphur, not quantity of enzyme present, is the limiting 
factor in the in vivo detoxification. 
THE USE OF CYANIDE AGAINST CANCER 
Since the late 1920's cyanide has been tested as an anti-neo-
plastic agent. Cyanide combines and forms a complex with iron (III) 
and other metals present in the respiratory enzyme systems of the cell. 
Very low concentrations of cyanide can inactivate the cytochrome oxi-
dase enzymes which catalyze oxidative phosphorylation, and the main 
supply of energy to the cell ceases. Hydroxycobalamin (Vitamin B12 ) 
and methemoglobin (iron (III) haemoglobin) also form complexes with 
cyanide. These two substances bind cyanide as strongly as the cyto-
chromes and have been used in the treatment of cyanide poisoning 
(Ferris, 1970). 
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Karczag (1928) found that with increasing doses of cyanide he 
could desensitize mice to the muscle cramping effects of KCN. Dosages 
of KCN administered to mice over periods of weeks and months influenced 
neither the longevity, the growth, the weight gain, lactation or any 
other biological process of normal animals. Karczag then inoculated 
these animals with Ehrlich Ascites Mouse Carcinoma and continued the 
administration of KCN. He found that the average life span of the 
treated animals was significantly prolonged over the controls, that 
tumor growth was slowed, and that 18% of the treated animals had a 
complete remission. He also noted no evidence of cyanide toxicity. 
Other studies using cyanide against cancer have been carried 
out. Maxwell and Bischoff (1933) exposed animals bearing transplant-
able tumors (Sarcoma 180, Walker 256 and R-10 sarcoma) to an atmosphere 
containing HCN (4%) for 5-6 hours daily during the life of the tumor. 
Although some animals sometimes showed anoxia and prostration there is 
no mention of chronic toxicity or mortality in treated animals. They 
conclude that exposure to hydrogen cyanide resulted in a decrease in 
the rate of tumor growth. A study carried out by Perry (1935), using 
the Jensen Sarcoma system of rats, also tested CN administered by in-
halation. However, a large number of the treated animals died as a 
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result of toxic effects, although all treated animals, alive and dead, 
showed marked tumor retardation. She concluded that the range of the 
effective dose was limited and too close to the lethal dose to be prac-
tical. More recently, a study was performed by Brown et al._ (1960) who 
used anesthesia to counter CN toxicity. Their results showed that NaCN 
administered via IV perfusions in several doses between 0.75 and 1.5 
mg/kg could produce life prolongations of 15-85% in Ehrlich Ascites 
Mouse Carcinoma, of 70% in Sarcoma 180 of rats, and in trials on 18 
dogs with spontaneous tumors, produced several apparent cures and a 
number of significant life prolongations, all without apparent acute or 
chronic toxicity. They obtained better results with those animals 
treated most frequently. They also gave results on limited clinical 
trials on seven terminal patients with gynecological cancer. They de-
tected no observable delayed clinical toxicity. But they did not find 
any clinical changes in these patients. However, the patients that 
were selected for the study were those in whom the disease was consid-
ered too far advanced to be amenable to the usual form of therapy and 
they were given only one 5-15 minute IV perifusion of .75-1.0 mg/kg. 
TOXICITY STUDIES ON AMYGDALIN 
As with any drug the toxic effects of amygdalin are governed by 
the size of the dose and the method or route of administration. A 
large number of toxicity studies has been carried out with amygdalin, 
however there is a great deal of inconsistency in the results obtained 
from them. Some of this discrepancy can be attributed to the mode of 
administration. It is well known that high doses given orally have not 
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proven to be as safe as intramuscular or intravenous injections of 
equally high doses (Manner~ al., 1978). According to Krebs (1970) 
amygdalin given orally could be 40 times more toxic than parenterally 
administered doses. Trube-Becker (1965) estimated that 50-70 raw al-
mond kernels would have to be eaten to provide a lethal dose to adults 
and as few as 7-10 almonds for a child. However, it has been shown 
that adult mice could live in perfect health to extreme old age when 
their diet consisted of fifty percent defatted aprical kernels (Griffin, 
1974). Schmidt et al. (1978) found that ~vhen dogs were given oral doses 
of Laetrile along with uncooked foods containing B-glucosidases there 
was a 60% mortality rate. Another study reported by the Cancer Commis-
sian of the California Medical Association (1953) indicated that amyg-
dalin administered to mice via gastric intubation was found to be safe 
at all doses below 300 mg/kg but once the doses reached 400 mg/kg or 
greater, death occurred in a matter of minutes to one hour. Stock et 
al. (1978) noted that oral dosages of amygdalin at 500 mg/kg/day were 
lethal while 250 mg/kg/day was tolerated for at least 19 doses. 
The greater toxicity of orally ingested amygdalin is attributed 
to the presence of the gastrointestinal flora which contain the enzyme 
beta-glucosidase. Studies by Carter et al. (1980) showed that ~vhen 
conventional rats were given single oral doses of amygdalin (600 mg/ 
kg) they usually died within 2 to 5 hours. On the other hand, germ 
free rats did not exhibit any visible signs of toxicity after receiv-
ing the same dose of amygdalin. Another study was carried out by 
Newton et al. (1981) to determine the role of the bacterial 
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flora of the gut in hydrolyzing amygdalin. Using rats, they found the 
LD 50 of amygdalin to be approximately 522 mg/kg of body weight. 'How-
ever, when rats were pre-treated with the antibiotic Neomycin which re-
duced the gastrointestinal flora, the rats became less susceptible to 
amygdalin's toxicity. 
A number of isolated cases of oral amygdalin toxicity have been 
found when there was accidental ingestion of too many kernels. Townsend 
(1975) reports of a 34 year old man who ingested approximately 48 ker-
nels and soon thereafter exhibited some symptoms of toxicity. He also 
states that the minimum number of kernels need to induce illness or 
death is not known. It should be noted that in a few places in the 
world, there are certain strains of apricot trees that produce seeds 
containing ten times the concentration of amygdalin found in those 
trees grown in the United States (Griffin, 1974). Some of these trees 
may be found in Turkey where it is culturally acceptable to eat apricot 
kernels. In 1964, a Turkish paper reported nine cases of cyanide pois-
oning, with two fatalities, from apricot seed ingestion during the per-
iod 1957-1962 (Sayre and Kaymakcalan, 1964). It has been reported that 
five to thirty apricot kernels eaten through the day may be a suffic-
ient preventative amount, but they should never be taken all at one 
time (Kirschman, 1979). Krebs (1967) suggests a minimum daily intake 
of fifty milligrams of amygdalin. The average apricot kernel in the 
United States contains approximately four to five milligrams of amygdal-
in. Thus, to obtain Kreb's recommended dose at 50 mg, one would 
have to ingest ten to twelve apricot kernels per day (Griffin, 1974). 
25 
Other routes of amygdalin administration have proven to be far 
less toxic. Two similar studies were carried out in 1975 administ.ering 
amygdalin intraperitoneally (Laster and Schabel, 1975; Wodinsky and 
Swiniarski, 1975). Wodinsky and Swiniarski reported that amygdalin MF 
was non-toxic for tumor-bearing mice when injected at a level of 64 mg/ 
mouse/day for 9 days, and that B-glucosidase could also be administered 
safely at a dose level of 0.2 mg/mouse. They observed toxicity only 
when B-glucosidase was administered before doses greater than or equal 
to 100 mg/kg of amygdalin MF. Studies by Laster and Schabel (1975) 
show that amygdalin MF alone was less toxic than when given with the 
activating agent, B-glucosidase. When only amygdalin MF was adminis-
tered to mice intraperitoneally for nine days it produced 60%mortality, 
at a dose of 500 mg/kg, 30% mortality at 355 mg/kg, and no deaths at 
220 mg/kg. However when B-glucosidase (10 mg/kg/dose) was given in 
combination with the amygdalin MF, the highest level that could be tol-
erated by normal mice without exceeding the LD 10 was 53 mg/kg/dose. 
Experiments by Hill ~ al. (1976) were carried out using intraperiton-
eal injections of amygdalin in mice. Their results indicate that at 
doses ranging from 50-500 mg/kg for 4 days there were no signs of tox-
icity, but when the dose was increased to 2000 mg/kg for 4 days there 
was a 5% death rate. Another experiment using intraperitoneal doses 
of amygdalin in mice was carried out by Stock et al. (1978). They 
noted that there was no toxicity from properly executed doses of amyg-
dalin as high as 1000 mg/kg/day from 6-28 injections and in one experi-
ment as high as 8000 mg/kg/day for 6 injections. Contrary to Stock's 
results are data from Khandekar and Edelman (1979) who report that 
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amygdalin given to Fischer 344 rats in doses of 250, 500, and 750 mg/kg 
intraperitoneally for five days, caused mortalities of 30.8%, 44.1%, 
and 56.8%, respectively. However, Stock~ al. (1978) responded to 
these data in a letter to the editor where he stated, "faulty intra-
peritoneal injections may have caused damage to the intestine by re-
leasing the enzyme B-glucosidase from the bacterial flora, which quick-
ly liberated cyanide from the amygdalin, causing mortality." 
A study was performed by Manner et al. (1977) where they in-
jected Jax C57 Bl/KsJ mice intramuscularly with doses ranging from 
1000-2500 mg/kg for 15 days. They found that daily doses of up to 
2000 mg/kg could be used without danger of toxicity. Amygdalin used 
in cancer therapy on adult humans has been administered in dosages of 
up to 70 grams by combined oral and parenteral routes without ill ef-
fects (Rubin, 1977). More recently, a pharmacologic test was carried 
out by the National Cancer Institute to look for possible toxic effects 
in a small number of cancer patients. Six patients entered the study; 
three received an IV formulation of Laetrile and three received it 
orally. The patients were also given foods containing the enzyme B-
glucosidase. They were all treated as in-patients and were closely 
monitored with blood and urine samples for cyanide and thiocyanate 
levels as well as any clinical evidence of cyanide toxicity. The re-
sults showed that five of the six patients experienced no toxic effects 
that could be directly or indirectly ascribed to Laetrile therapy. One 
patient showed clinical evidence of toxicity only after eating large 
quantities of raw almonds (Henney, 1980). 
27 
PREVENTION STUDIES WITH AHYGDALIN 
There are very few controlled laboratory experiments using amyg-
dalin for cancer prevention. In reviewing the literature only one set 
of two prevention studies using spontaneous tumors in mice could be 
found (Stock et al., 1978). Both of these experiments were performed 
by Stock's co-worker, Kanematsu Sugiura. In the first prophylaxis ex-
periment he used CD8 F1 mice, a strain which develops spontaneous mam-
mary tumors. Mice in the experimental group received daily intraperi-
toneal injections of amygdalin 6 times per week at a dosage of 1000 mg/ 
kg/day. The control group received 0.5 ml injections of physiological 
saline. Although five experimental animals were killed accidentally by 
the injection of amygdalin into the intestine or in the uterine horn of 
pregnant mice, he still obtained interesting results. In 30 control 
animals 81% developed lung metastases and 82% tumors. In 24 experi-
mental animals 17% developed lung metastases and 72% tumors. The aver-
age number of days for tumor development were 411 and 449 in control 
and experimental mice, respectively. The second prophylaxis experiment, 
also performed by Sugiura, tested amygdalin against spontaneous leukem-
ia in &~R mice. The mice were divided into 2 groups, one to receive IP 
injections of 0.5 ml saline daily six times per week and the other to 
receive 2000 mg/kg/day of amygdalin. His findings show that in none of 
the mice was there prevention of the development of leukemia or signif-
icant increase in the survival of the mice. However, they do state 
that it might have been less of a challenge to the amygdalin if younger 
mice further from the occurrence of leukemia had been used. 
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Only t'vo other similar laboratory experiments on cancer preven-
tion with amygdalin could be found. However, in these studies trans-
plantable tumors were used instead of spontaneous tumors. One was a 
study by Reitnauer which was published in 1974. He pretreated 20 out 
of 40 H strain mice with bitter almonds which were taken in addition to 
their standard feed in a free food .choice. After fifteen days of pre-
treatment, all 40 mice were innoculated with 10 6 Ehrlich Ascites cells. 
The 20 control mice lived an average of 21.9 days follmv-ing the trans-
plant. The 20 mice who received bitter almonds throughout the experi-
ment lived an average of 25.8 days (p < 0.05 by t-test). Another ex-
periment was carried out in France in 1977 by Metianu. Ten controls 
and 10 mice treated subcutaneously two to three times per week for 20 
to 25 days with 500 mg/kg of amygdalin were injected with 5 x 108 cells 
of an adenocarcinoma adapted for mice. The experimental group lived an 
average of 58 days past the time of tumor take, while the control group 
averaged 21 days survival. To see if the results could be replicated, 
he repeated the same experiment and found the experimental group to 
live 47 days past the time of tumor take, and 27 days survival for the 
controls. He obtained less noticeable results with higher doses, and 
observed no effect with amygdalin at 100 mg/kg. 
USE OF THE FE:HALE C3H/HeJ HOUSE 
Among all of the laboratory mammals, the common mouse is the 
most widely used (Green, 1966). Advantages of using themouse include 
easy availability of inbred strains from national or regional stock 
centers (i.e. Jackson Laboratories), the large amount of information 
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known on their genetics and biology, low cost, and small size, which 
minimizes care and space. The latter two advantages are of particular 
importance when carrying out large scale, long term (2 years) preven-
tion studies such as this one. 
The rodent tumor selected to evaluate the anti-tumor properties 
of naturally occurring amygdalin was the spontaneous murine mammary 
adenocarcinoma. Mammary tumors (in breeding females) are the most com-
mon tumors of inbred strains of mice and are probably the most complete-
ly studied of all tumors (Dunn, 1959). Spontaneous mammary tumors from 
inbred strains of mice form one of the most useful groups of neoplasms 
for certain investigations in the field of cancer research (Auduvant 
and McEleney, 1940). Advantages of using this tumor include accessi-
bility to palpation and predictable frequency in a number of inbred 
strains. Therefore, the mammary tumor has been an invaluable tool for 
investigations in genetic, viral, hormonal, chemotherapeutic, nutrition-
al and other facets on cancer research (Green, 1966). 
Another important reason for using this rodent tumor is that it 
is a spontaneous type of tumor. There seems to be some basis for con-
sidering spontaneous tumors to be a truer model of the situations of 
medical interest, both in growth characteristics and in treatability 
(Martinet al., 1975). 
The mouse chosen for this study is the female C3H/HeJ strain. 
This strain of mouse was selected because it has been used previously 
by investigators in our laboratory (Manner et al., 1978). Also, the 
C3H strain of mouse is typical of one of the high-incidence strains 
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produced through brother-and-sister mating. In breeding females, spon-
taneous mammary tumors are usually observed at about 8~ months and the 
average duration of life after the tumor is 6 to 7 weeks (Lippincott et 
al., 1942). Thus, strain C3H females are useful in studies on the oc-
currence of spontaneous mammary cancer in mice since the high incidence 
supplies satisfactory controls for experiments in the inhibition of the 
tumors (Auduvant and McEleney, 1940). 
CHAPTER III 
MATERIALS AND METHODS 
PREVENTION STUDY 
For the prevention experiment, one hundred and fifty female C3H/ 
HeJ mice, Mus musculus, were obtained from Jackson Laboratories in Bar 
Harbor, Maine. These mice were retired breeders and when received were 
approximately 8 months of age. These mice have a mean life span of ap-
proximately 18 months. Female C3H/HeJ mice are genetically bred for 
approximately a 60% maximum cumulative incidence of mammary tumors 
(Jackson Laboratories, 1979). The average weight of the mice was 30 
grams. Initially, these mice were housed 4 in a cage (plastic shoe-box 
type) containing an inert bedding called Sanicel. 
The environmental conditions were kept constant. Water bottles 
were checked daily and cages changed routinely. Humidity was kept be-
tween 50-55%; room temperature, 23 ± 2° C; photoperiod twelve hours of 
light and twelve hours of darkness. All animals received standard 
Purina Mouse Chow and tap water ad libitum. 
This study was initiated on September 17, 1979. Prior to ex-
perimentation, all animals were screened by palpation for the presence 
of spontaneous mammary tumors. Only those mice without any tumors were 
used at the start of this study. Forty-five control animals were 
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maintained on the standard diet above. Eighty experimental animals re-
ceived apricot kernels ad libitum in addition to their standard diet. 
The apricot kernels were obtained from American Nutrition Products, 
Thousand Oaks, California and were stored at 5° C. Apricot kernels are 
the primary source of amygdalin and on analysis contain 2 to 3% amyg-
dalin and also substantial amounts of protein, unsaturated fatty acids, 
and minerals (Kirschman, 1973). Evidence of apricot kernel consumption 
by the animals was noted by observation. 
The animals were palpated thoroughly each day until a tumor was 
found. Once a tumor was found, the length of time for appearance was 
recorded, and thereafter, the mice were caged separately and observed 
for tumor growth or recession, longevity, and general appearance. Ex-
perimental animals with mammary tumors continued to receive apricot 
kernels ad libitum. All animals were maintained until death, so that 
a mortality rate could be established. 
TOXICITY STUDIES 
Another study was carried out to investigate for any possible 
toxic effects that might be incurred when chronic low doses of amygdalin 
are administered via the oral route. 
Forty female C3H/HeJ mice without tumors were used for this 
study. They were caged separately and fed Purina Mouse Chow and tap 
water ad libitum. The mice were divided into four groups of ten. The 
first group received a daily dosage of natural amygdalin dissolved in 
their drinking water. The amount of amygdalin used was equivalent to 
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3% (the approximate amount of amygdalin in apricot kernels). Another 
group received a daily dosage of natural amygdalin equivalent to 250mg/ 
kg. The third group received daily dosages of natural amygdalin which 
were increased each day until toxic effects were noted. In the latter 
two groups the amygdalin was dissolved in distilled, deionized water 
and administered orally via gastric incubation after methods of Simmons 
and Brick (1970). The last group was maintained as a control group and 
received distilled, deionized water via gastric intubation in a dosage 
volume equivalent to the experimental groups. The amygdalin used was 
obtained from Sigma Chemical Company, St. Louis, Missouri and was ap-
proximately 99% pure. The amygdalin solutions were prepared fresh 
daily. 
All animals were weighed at the beginning of the experiment and 
again at the end and weight changes were noted. Observations were made 
twice daily, and all signs of toxicity were recorded. 
CHAPTER IV 
RESULTS 
PREVENTION STUDY 
The mice in this study were categorized into t'vo groups. Group 
1 (controls) represents the mice that did not receive apricot kernels 
and Group 2 (experimental) represents the mice that did receive apricot 
kernels. 
The number of mice that formed spontaneous mammary tumors was ex-
amined in both groups. The results can be seen in Figure 5. In the 
control group, 77.8% of the animals formed tumors, and in the experi-
mental group 78.8% of the animals formed tumors. This does not repre-
sent a significant difference. 
The mean time for the tumors to develop was also examined. The 
results are represented in Figure 6. The mean number of months requir-
ed for tumor formation in the control group was 5.9 ± 3.5 months and in 
the experimental group it was 6.8 ± 3.6 months. This was not found to 
be significantly different. 
This experiment also evaluated the effects of apricot kernels on 
the mean life span of the mice. Figure 7 shows a comparison between the 
non-tumorous control and experimental animals and the tumorous control 
and experimental animals. Non-tumorous mice in the control group lived 
a mean of 18.8 ± 3.3 months and those in the experimental group lived a 
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FIGURE 5. Percentage of tumorous mice in control and experimental 
groups. 
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FIGURE 6. Hean number of months required for tumor formation. 
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mean of 18.0 ± 2.9 months. Tumorous mice in the control group lived a 
mean of 16.6 ± 3.8 months and tumorous mice in the experimental gr9up 
lived a mean of 17.6 ± 3.5 months. The difference in the mean life span 
of mice in either of these groups was not found to be significantlydif-
ferent. 
To ensure thorough evaluation of the data, comparisons were made 
between the mean life span of tumorous mice in the control group and 
non-tumorous mice in both the control and experimental groups. Compar-
isons were also made between the mean life span of tumorous mice in the 
experimental group and non-tumorous mice in the control and experiment-
al groups. In both of these comparisons, there could be found no sig-
nificant difference in the mean life span of the mice (see Figure 8). 
TOXICITY STUDY 
The results from the toxicity study are given in Table III. In 
mice given a 3% solution of amygdalin, seven out of ten mice died after 
the first day and the three remaining mice were dead after the second 
day. This represents a cumulative mortality of 100%. When amygdalin 
was administered in an oral dose of 250 mg/kg/day for fifteen days, 
there was one death out of ten animals. When the dose was escalated to 
400 mg/kg/day for fifteen days there were five deaths after one day; 
five more deaths after two days. This represents a cumulative mortali-
ty of 100% and suggests that the LDso of orally ingested amygdalin lies 
approximately around this dose. In the control group which received 
distilled, deionized water by gastric intubation, there was one death 
out of ten animals. 
FIGURE 8. Comparison between tumorous and non-tumorous control and 
experimental mice, 
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TABLE III. Effects of orally ingested amygdalin on mortality of female C3H/HeJ mice. 
Mortality Distribution 
Dose of No. of (Day) 
Group Amygdalin Animals 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
A 3% Solution 10 7 3 
B 250 rug/kg 10 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
c 400 rug/kg 10 5 5 
D Controls 10 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 
Mortality % 
100 
10 
100 
10 
~ 
0 
CHAPTER V 
DISCUSSION 
These studies on the toxicity and cancer preventive effects of 
orally ingested natural amygdalin were performed to help provide fur-
ther information about the importance of this substance in everyday 
human use. They are important because it is estimated that 70,000 
people in the United States alone have used amygdalin in an attempt to 
fight cancer and 22 states have legalized its use (Sun Times, 1981). 
Also, apricot kernels and similar pits and seeds are sold in health 
food stores and are widely promoted as having disease preventive or 
curative properties (Townsend and Boni, 1975). 
In the prevention study, apricot kernels were given to female 
C3H/HeJ mice along with their standard feed in a free food choice. The 
experimental design was similar to that of Reitnauer (1974) and should 
simulate the same procedures that are used in humans for cancer preven-
tion. One drawback with this design, however, is that there is no way 
of determining with any degree of certainty the precise amount of amyg-
dalin that was ingested by the mice. Thus, the possibility exists that 
some of the mice in the experimental group may not have eaten the apri-
cot kernels at all. However, based on observations there was positive 
evidence of consumption of the apricot kernels by all of the mice. 
Apricot kernels were chosen because they are the primary source of 
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amygdalin and are commonly used by proponents of amygdalin for preven-
tion of cancer. 
The results fromthispreliminary prevention study appear to in-
dicate that apricot kernels do not prevent the formation of spontaneous 
mammary tumors in female C3H/HeJ mice, nor do they appear to prolong 
the onset of tumor formation (Figures 5 and 6). In the experimental 
group, the formation of tumors was delayed by a mean of 0.93 months, 
but this was not found to be statistically significant using a correct-
ed two-tailed Student's t-test. These data confirm the results of Stock 
et al. (1978) who found that amygdalin injected intraperitoneally had 
no significant preventive effect on the formation of spontaneous mam-
mary tumors in CD 8F1 mice and spontaneous leukemia in AKR mice. 
This study also analyzed the effects of the apricot kernels on 
the longevity of the mice. The mice in the experimental group that 
formed tumors lived a mean of 0.99 months longer than those in the con-
trol group that formed tumors, but this was not found to be significant-
ly different. But no significant difference could be found in the mean 
life span of the mice that didn't form tumors in the control and exper-
imental groups (Figure 7). These results seem to indicate that the 
apricot kernels are not having any toxic effects which would alter the 
life span of the experimental mice. 
At this time it seems appropriate to mention one other factor 
that may lend some error to the interpretation of the results. When 
handling the data statistically, only the mean age of the mice was 
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known when they were obtained from the supplier. Therefore, the data, 
which was recorded in days, was converted to months. This was done to 
compensate for any possible sample error. 
Several important assessments can be made from the data in the 
toxicity studies. In the mice that received 3% amygdalin in their 
drinking water, there was a cumulative mortality of 100%. These re-
sults are agreeable with those found elsewhere in the literature. In 
an article by Sayre and Kaymakcalan (1964) it indicates that amygdalin 
present in the seed is harmless as such. However, when the seed is 
crushed and the pulp is placed in the presence of water, the catalysis 
of amygdalin is enhanced and the amygdalin is broken down into its con-
stituent parts, one of them being hydrocyanic acid. The results of this 
experiment would explain the report of a 34 year old man who developed 
symptoms of cyanide poisoning after crushing up 48 apricot kernels and 
mixing them with milk and honey before ingesting them (Townsend and 
Bani, 1975). These results also seem to confirm the results of Schmidt 
et al. (1978) who found that sweet almonds (which contain the enzyme 
B-glycosidase), amygdalin and water mixed together in a blender then 
administered to dogs after various incubation times caused toxiceffects. 
In a nutrition almanac by Kirschman (1979) it states, "it is not con-
sidered desirable to prepare a slurry of ground up kernels (as in a 
solution of water, milk, or orange juice) and then let it stand for 
long periods of time before consumption." Thus, the results from this 
present toxicity study support this statement as well as the previously 
mentioned studies of Schmidt et al. and Townsend and Bani. 
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The present toxicity studies also looked at the daily oral dose 
of amygdalin that could be tolerated by the mice and the oral dos~ of 
amygdalin required to exhibit toxic effects. It may be concluded from 
the data that daily oral doses of amygdalin at 250 mg/kg/day are non-
toxic in mice, but when the dosage is increased to 400 mg/kg/day there 
is a 50% mortality rate. These results confirm those obtained by the 
Cancer Commission of the California Medical Association (1953). Al-
though one death was found in the 250 mg/kg/day group, this was not 
found to be significant when compared with the controls. The cause of 
death could be attributed to stress or trauma as a result of adminis-
tering the solutions by gastric intubation. 
As proposed by advocates of amygdalin, the number of apricot 
kernels that should be eaten for a preventive effect is five to thirty 
kernels (Krebs, 1967; Kirschman, 1979). The average apricot kernel 
grown in the United States contains approximately four to five milli-
grams of amygdalin (Griffin, 1974). Using this average figure, the 
amount of amygdalin in five to thirty kernels would be 25 to 150 mg/day. 
For a 70 kg man, this is 0.36 to 2.14 mg/kg/day. As mentioned previous-
ly the dose required to produce toxic effects in mice was found to be 
400 mg/kg/day and since humans are seven times more sensitive to the 
lethal effects of standard chemotherapeutic agents than mice (Freireich 
et al., 1966) this translates into 57 mg/kg/day for humans. Therefore, 
it appears that the recommended dose of amygdalin for prevention would 
not appear to be toxic in humans. However, as in any experiment using 
laboratory animals one must be extremely cautious about extrapolations 
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from observations on mice directly to humans (Good, 1981). 
In summary, the data presented here indicate that apricot ker-
nels by themselves have no real important effects on the inhibition of 
tumor growth in mice. The results from the toxicity studies do show 
that when natural amygdalin is ingested in biologically rational doses 
it is non-toxic. One point that should be mentioned is that the exact 
amount of amygdalin that was ingested by the mice in the prevention 
study was unknown, therefore the possibility exists that the dosage of 
amygdalin obtained by the mice was too low to have had a preventive ef-
fect. Future studies on naturally occurring amygdalin could be carried 
out using a Mouse Chow with various known concentrations of amygdalin 
incorporated into it and caging the mice separately. That way the 
amount of amygdalin consumed by the mice could be more accurately mon-
itored. 
Another explanation for the ineffectiveness of the apricot ker-
nels in preventing tumor formation is the fact that they were the only 
modality used. In previous studies by Manner et al. (1978), it was 
found that amygdalin used alone was not effective in suppressing tumor 
formation, but when used in conjunction with a complete metabolic ther-
apy program, it was found to be effective. In light of this fact, a 
future experiment on cancer prevention should be carried out using 
naturally occurring amygdalin in conjunction with a complete metabolic 
program. 
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